Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Valine activating enzyme

Derepression of Isoleucine-Valine Biosynthetic Enzymes in Escherichia coli Relative Specific Activities ... [Pg.456]

Effect of an ilv S Mutation on Isoleucine Valine Biosynthetic Enzymes Relative Specific Activity"... [Pg.459]

When the transfer of activated valine from enzyme to tRNA is measured at various temperatures, the transfer is quantitative up to 55° C, but then it drops slowly between 55 and 60° C (80% of transfer at 60° C) and rapidly between 60 and 65° C (no transfer at 65° C). Yet at 65° C the enzyme catalyzes the amino acid acylation at normal rates. Again the findings were interpreted to mean that conformational changes in tRNA interfered with its ability to react with the enzyme. Transfer RNA forms a link between most of the individual components involved in protein synthesis, amino acyl RNA, ribosomes, and messenger RNA. [Pg.113]

Fig. 5.15. The charging of t-RNA. The diagram shows the selection of phenylalanine by t-RNA (phenylalanine t-RNA) from a group of activated amino acids. ENZ, amino acid activating enzyme PHE, phenlyalanine VAL, valine MET, methionine ASP, aspartic acid. The diagram of t-RNA " illustrates the anticodon loop and a double stranded helical portion of the molecule. The full clover leaf structure is not represented. The black square adjacent to the anticodon illustrates the position occupied by isopenteny-aminopurine in some plant t-RNAs (see p. 299). Fig. 5.15. The charging of t-RNA. The diagram shows the selection of phenylalanine by t-RNA (phenylalanine t-RNA) from a group of activated amino acids. ENZ, amino acid activating enzyme PHE, phenlyalanine VAL, valine MET, methionine ASP, aspartic acid. The diagram of t-RNA " illustrates the anticodon loop and a double stranded helical portion of the molecule. The full clover leaf structure is not represented. The black square adjacent to the anticodon illustrates the position occupied by isopenteny-aminopurine in some plant t-RNAs (see p. 299).
Interest in JAK2 inhibitors for the treatment of MPN was bolstered by the discovery of a point mutation in JAK2 at position 617 (valine to phenylalanine, V617F) in the majority of patients with MPN [2,3]. This mutation occurs in the JH2 pseudokinase domain and relieves an autoinhibitory function of this domain, constitutively activating the catalytic function of the kinase via a cytokine-independent mechanism. Although this is the predominant mutation in the disease, additional mutations in the enzyme, its receptor, or within other levels of the network have also been identified that result in JAK2-STAT pathway activation [5-9] (Figure 1). [Pg.212]

As noted by the original authors (Dorovska et al., 1972), and cited by Fersht (1985), there is an excellent linear correlation between log/ccat/KM and the Hansch hydrophobicity parameters (v) of the side chains (Fig. 9, A), except for the two branched side chains (valine and isoleucine residues). However, since the ku values for the esters do vary somewhat (Table A6.8), the values of pKrs do not correlate as strongly with ir (Fig. 9, B). Moreover, the plot shows distinct curvature which probably indicates the onset of a saturation effect due to the physical limits of the Sj binding pocket, adjacent to the enzyme s active site. Still, the points for valine and isoleucine deviate below the others, suggesting that the pocket has a relatively narrow opening. [Pg.60]

Capsaicinoids are synthesized by the condensation of vanillylamine with a short chain branched fatty acyl CoA. A schematic of this pathway is presented in Fig. 8.4. Evidence to support this pathway includes radiotracer studies, determination of enzyme activities, and the abundance of intermediates as a function of fruit development [51, 52, 57-63], Differential expression approaches have been used to isolate cDNA forms of biosynthetic genes [64-66], As this approach worked to corroborate several steps on the pathway, Mazourek et al. [67] used Arabidopsis sequences to design primers to clone the missing steps from a cDNA library. They have expanded the schema to include the biosynthesis of the key precursors phenylalanine and leucine, valine and isoleucine. Prior to this study it was not clear how the vanillin was produced, and thus the identification of candidate transcripts on the lignin pathway for the conversion of coumarate to feruloyl-CoA and the subsequent conversion to vanillin provide key tools to further test this proposed pathway. [Pg.118]

Catalases have proven to be a treasure trove of unusual modifications. The first noted modification was the oxidation of Met53 of PMC to a methionine sulfone (77). Met53 is situated in the distal side active site adjacent to the essential His54 in a location where oxidation by a molecule of peroxide would not be unexpected. Among the catalases whose structures have been solved, PMC is unique in having the sulfone because valine is the more common replacement in other catalases. The sulfone does not seem to have a role in the catalytic mechanism and is clearly generated as a posttranslational modification. A small number of catalases from other sources, principally bacteria, have Met in the same location as PMC, and it is a reasonable prediction that the same oxidation occurs in those enzymes as well, although this has not been demonstrated. [Pg.94]

Acyclovir Zovirax) is a guanine nucleoside analogue most effective against HSV-1 and HSV-2, but it has some activity against VCV, CMV, and EBV. Valacyclovir (Valtrex) is the L-valine ester prodrug of acyclovir. Acyclovir is converted to its active metabolite via three phosphorylation steps. First, viral thymidine kinase converts acyclovir to acyclovir monophosphate. Next, host cell enzymes convert the monophosphate to the diphosphate and then to the active compound, acyclovir triphosphate. Because viral thymidine kinase has a much greater affinity for acyclovir triphosphate than does mammalian thymidine kinase, acyclovir triphosphate accumulates only in virus-infected cells. [Pg.569]

Various amino acids have been replaced by 4-F-Phe or hexafluorovaline in peptidic hormones oxytocin (4-F-Phe —> lyr), bradykinin (4-F-Phe —> Phe), and angiotensin II. The consequences are diverse, but the stability toward hydrolytic enzymes is generally enhanced. Thus, incorporation of Fs-valine in an octapeptide antagonist of angiotensin II (Sar-AII) notably enhances its in vivo antagonist activity. Analogues of TRH (thyrotropin-releasing hormone), in which histidine is replaced by a fluor-ohistidine (4-F-His and 2-F-His —> His), have better in vivo activities, while the affinities are lower. [Pg.170]


See other pages where Valine activating enzyme is mentioned: [Pg.216]    [Pg.146]    [Pg.491]    [Pg.135]    [Pg.165]    [Pg.188]    [Pg.346]    [Pg.165]    [Pg.108]    [Pg.286]    [Pg.302]    [Pg.374]    [Pg.782]    [Pg.21]    [Pg.180]    [Pg.511]    [Pg.515]    [Pg.608]    [Pg.92]    [Pg.336]    [Pg.471]    [Pg.139]    [Pg.136]    [Pg.71]    [Pg.85]    [Pg.214]    [Pg.215]    [Pg.269]    [Pg.1137]    [Pg.233]    [Pg.4]    [Pg.149]    [Pg.89]    [Pg.372]    [Pg.165]    [Pg.74]    [Pg.106]    [Pg.1137]    [Pg.94]   
See also in sourсe #XX -- [ Pg.287 ]




SEARCH



Valin

© 2024 chempedia.info